Detalhe da pesquisa
1.
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
N Engl J Med
; 385(20): 1845-1855, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758252
2.
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
Eur Heart J
; 44(8): 668-677, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632831
3.
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial.
Eur Heart J
; 44(24): 2202-2212, 2023 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051752
4.
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
Eur Heart J
; 44(31): 2982-2993, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210743
5.
Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.
Circulation
; 146(14): 1067-1081, 2022 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082663
6.
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.
Circulation
; 146(23): 1749-1757, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36321459
7.
The Effect of Sacubitril/Valsartan on Left Ventricular Myocardial Deformation in Heart Failure with Preserved Ejection Fraction (PARAMOUNT trial).
J Card Fail
; 29(6): 968-973, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031887
8.
Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial.
J Card Fail
; 29(11): 1494-1503, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220823
9.
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
N Engl J Med
; 381(17): 1609-1620, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31475794
10.
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.
Cardiovasc Diabetol
; 21(1): 110, 2022 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717169
11.
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction.
Circulation
; 142(13): 1236-1245, 2020 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32845715
12.
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
Circulation
; 141(5): 352-361, 2020 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736342
13.
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction.
Eur Heart J
; 41(25): 2356-2362, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32221596
14.
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
Circulation
; 140(17): 1369-1379, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31510768
15.
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction.
Circulation
; 146(18): 1411-1414, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029463
16.
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial.
Circulation
; 145(1): 87-89, 2022 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797725
17.
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.
Eur Heart J
; 38(15): 1132-1143, 2017 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28158398
18.
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
Circulation
; 133(23): 2254-62, 2016 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27143684
19.
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
N Engl J Med
; 371(11): 993-1004, 2014 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25176015
20.
The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
Am Heart J
; 188: 35-41, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577679